Showing results (321-330 of 365) with videos related to

Sort By:
Pageof 37
Journal of the National Cancer Institute|April 21, 1993
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancerS A Rosenberg, M T Lotze, J C Yang, et al.
Journal of the National Cancer Institute|November 15, 1989
In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanomaK D Griffith, E J Read, J A Carrasquillo, et al.
Annals of Surgery|October 1, 1993
The development of gene therapy for the treatment of cancerS A Rosenberg, W F Anderson, M Blaese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanomaB Fisher, B S Packard, E J Read, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1991
Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcomaS F Stinson, T F DeLaney, J Greenberg, et al.
The New England Journal of Medicine|December 22, 1988
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary reportS A Rosenberg, B S Packard, P M Aebersold, et al.
Zhonghua Yi Xue Za Zhi|May 21, 2025
[Association between KLK10 gene methylation in female breast tumor tissue and the risk of invasive breast cancer]J C Yang, Y F Yin, Q Zhu, et al.
Cancer Research|November 3, 2001
Immunization against endogenous retroviral tumor-associated antigensM H Kershaw, C Hsu, W Mondesire, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2015
Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong KongC L Lai, V W-S Wong, M F Yuen, et al.
Journal of the National Cancer Institute|January 5, 1994
Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancerD J Cole, M G Sanda, J C Yang, et al.
Pageof 37